Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWFT
2026
PUT
DELISTED
Swift Transportation Company
SWFT
| $5.95M | ﹤0.01% |
277,200
+142,800
| +106% | +$2.71M |
|
|
ETFC
2027
DELISTED
E*Trade Financial Corporation
ETFC
| $5.95M | ﹤0.01% |
204,249
-86,447
| -30% | -$2.23M |
|
|
ACOR
2028
PUT
DELISTED
Acorda Therapeutics
ACOR
| $5.94M | ﹤0.01% |
2,369
+1,786
| +306% | +$5.33M |
|
2029
CALL
KB Home
KBH
$3.44B
| $5.92M | ﹤0.01% |
367,300
-148,900
| -29% | -$2.34M |
|
2030
CALL
Terex
TEX
$7.47B
| $5.91M | ﹤0.01% |
232,600
+26,700
| +13% | +$622K |
|
|
GPOR
2031
PUT
DELISTED
Gulfport Energy Corp.
GPOR
| $5.91M | ﹤0.01% |
209,100
+96,600
| +86% | +$2.75M |
|
|
NE
2032
CALL
DELISTED
Noble Corporation
NE
| $5.9M | ﹤0.01% |
931,100
-47,500
| -5% | -$319K |
|
2033
CALL
Cimpress
CMPR
$2.12B
| $5.9M | ﹤0.01% |
58,300
+31,500
| +118% | +$3.07M |
|
|
MRSH
2034
Marsh
MRSH
$92.2B
| $5.9M | ﹤0.01% |
87,700
| – | – |
|
2035
CALL
Cintas
CTAS
$82.3B
| $5.89M | ﹤0.01% |
209,200
+38,800
| +23% | +$1.06M |
|
|
VNET
2036
PUT
VNET Group
VNET
$1.88B
| $5.88M | ﹤0.01% |
740,100
+77,000
| +12% | +$711K |
|
2037
PUT
Quanta Services
PWR
$92.7B
| $5.88M | ﹤0.01% |
+210,200
| New | +$5.35M |
|
|
WP
2038
DELISTED
Worldpay, Inc.
WP
| $5.88M | ﹤0.01% |
104,477
+40,841
| +64% | +$2.27M |
|
2039
CALL
PG&E
PCG
$40.1B
| $5.88M | ﹤0.01% |
96,100
+48,900
| +104% | +$3.1M |
|
2040
PUT
ProShares UltraShort Russell2000
TWM
$44.2M
| $5.88M | ﹤0.01% |
10,190
-3,180
| -24% | -$1.95M |
|
|
OAK
2041
PUT
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $5.87M | ﹤0.01% |
138,400
-9,100
| -6% | -$407K |
|
2042
PUT
The Greenbrier Companies
GBX
$1.43B
| $5.86M | ﹤0.01% |
166,100
-166,400
| -50% | -$5.45M |
|
2043
Lumen
LUMN
$6.28B
| $5.86M | ﹤0.01% |
213,600
| – | – |
|
|
TMUSP
2044
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $5.86M | ﹤0.01% |
+75,000
| New | +$5.79M |
|
|
OCLR
2045
PUT
DELISTED
Oclaro Inc.
OCLR
| $5.85M | ﹤0.01% |
+684,500
| New | +$4.76M |
|
2046
CALL
Vanguard Morningstar Mid-Cap ETF
VO
$110B
| $5.84M | ﹤0.01% |
180,400
+23,200
| +15% | +$744K |
|
2047
Rockwell Automation
ROK
$47.9B
| $5.83M | ﹤0.01% |
47,674
+6,474
| +16% | +$757K |
|
2048
Intuit
INTU
$94.6B
| $5.83M | ﹤0.01% |
53,000
-1,902
| -3% | -$213K |
|
|
ARIA
2049
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $5.83M | ﹤0.01% |
425,900
-241,300
| -36% | -$2.42M |
|
|
CRC
2050
CALL
DELISTED
California Resources Corporation
CRC
| $5.83M | ﹤0.01% |
466,500
+55,100
| +13% | +$629K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.